Diaphorina citri psyllid: psy1103

Local Sequence Feature Prediction

Prediction and MethodResult
Residue Number Marker
Protein Sequence ?
Secondary Structure (Consensus) ?
Disordered Region (Consensus) ?
Transmembrane Helix (Consensus) ?
Signal Peptide (Consensus) ?
Coiled Coil (COILS) ?
 
--------10--------20--------30--------40--------50--------6
MAPEVLEFCVSSETSEIDIAPNTRVGTRRYMAPEVLDETIDTKFFDAFKMADMYSLGPT
cccEEEEEEECccccccccccccccccccccccHHHcccccccccHHHHHHHccccccc
**PEVLEFCVSSETSEIDIAPNTRVGTRRYMAPEVLDETIDTKFFDAFKMADMYSLGPT
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MAPEVLEFCVSSETSEIDIAPNTRVGTRRYMAPEVLDETIDTKFFDAFKMADMYSLGPT

Function Prediction

Annotation transfered from Closely Related SWISS-PROT Entries ?

Annotation ?Function Description ?Confidence Level ?Reference Protein ?
Activin receptor type-1B Transmembrane serine/threonine kinase activin type-1 receptor forming an activin receptor complex with activin receptor type-2 (ACVR2A or ACVR2B). Transduces the activin signal from the cell surface to the cytoplasm and is thus regulating a many physiological and pathological processes including neuronal differentiation and neuronal survival, hair follicle development and cycling, FSH production by the pituitary gland, wound healing, extracellular matrix production, immunosuppression and carcinogenesis. Activin is also thought to have a paracrine or autocrine role in follicular development in the ovary. Within the receptor complex, type-2 receptors (ACVR2A and/or ACVR2B) act as a primary activin receptors whereas the type-1 receptors like ACVR1B act as downstream transducers of activin signals. Activin binds to type-2 receptor at the plasma membrane and activates its serine-threonine kinase. The activated receptor type-2 then phosphorylates and activates the type-1 receptor such as ACVR1B. Once activated, the type-1 receptor binds and phosphorylates the SMAD proteins SMAD2 and SMAD3, on serine residues of the C-terminal tail. Soon after their association with the activin receptor and subsequent phosphorylation, SMAD2 and SMAD3 are released into the cytoplasm where they interact with the common partner SMAD4. This SMAD complex translocates into the nucleus where it mediates activin-induced transcription. Inhibitory SMAD7, which is recruited to ACVR1B through FKBP1A, can prevent the association of SMAD2 and SMAD3 with the activin receptor complex, thereby blocking the activin signal. Activin signal transduction is also antagonized by the binding to the receptor of inhibin-B via the IGSF1 inhibin coreceptor. ACVR1B also phosphorylates TDP2.confidentQ61271
Activin receptor type-1B Transmembrane serine/threonine kinase activin type-1 receptor forming an activin receptor complex with activin receptor type-2 (ACVR2A or ACVR2B). Transduces the activin signal from the cell surface to the cytoplasm and is thus regulating a many physiological and pathological processes including neuronal differentiation and neuronal survival, hair follicle development and cycling, FSH production by the pituitary gland, wound healing, extracellular matrix production, immunosuppression and carcinogenesis. Activin is also thought to have a paracrine or autocrine role in follicular development in the ovary. Within the receptor complex, type-2 receptors (ACVR2A and/or ACVR2B) act as a primary activin receptors whereas the type-1 receptors like ACVR1B act as downstream transducers of activin signals. Activin binds to type-2 receptor at the plasma membrane and activates its serine-threonine kinase. The activated receptor type-2 then phosphorylates and activates the type-1 receptor such as ACVR1B. Once activated, the type-1 receptor binds and phosphorylates the SMAD proteins SMAD2 and SMAD3, on serine residues of the C-terminal tail. Soon after their association with the activin receptor and subsequent phosphorylation, SMAD2 and SMAD3 are released into the cytoplasm where they interact with the common partner SMAD4. This SMAD complex translocates into the nucleus where it mediates activin-induced transcription. Inhibitory SMAD7, which is recruited to ACVR1B through FKBP1A, can prevent the association of SMAD2 and SMAD3 with the activin receptor complex, thereby blocking the activin signal. Activin signal transduction is also antagonized by the binding to the receptor of inhibin-B via the IGSF1 inhibin coreceptor. ACVR1B also phosphorylates TDP2.confidentP80202
Serine/threonine-protein kinase sma-6 Involved in TGF-beta pathway. May be a receptor for daf-7.confidentQ09488

Prediction of Gene Ontology Terms ?

GO Term ?Description ?Confidence Level ?Parent GO Terms ?
GO:0008150 [BP]biological_processconfident
GO:1901165 [BP]positive regulation of trophoblast cell migrationprobableGO:2000243, GO:2000241, GO:0050789, GO:0065007, GO:0048518, GO:2000145, GO:1901163, GO:0030335, GO:0030334, GO:0050793, GO:0050794, GO:0043900, GO:0051270, GO:0008150, GO:0051239, GO:0032879, GO:0051272, GO:0040012, GO:0040017, GO:2000026, GO:2000147, GO:0048522
GO:0046332 [MF]SMAD bindingprobableGO:0003674, GO:0005488, GO:0005515
GO:0010862 [BP]positive regulation of pathway-restricted SMAD protein phosphorylationprobableGO:0019220, GO:0009893, GO:0019222, GO:0031325, GO:0048584, GO:0048583, GO:0023056, GO:0023051, GO:0010647, GO:0010646, GO:0050789, GO:0080090, GO:0010604, GO:0090100, GO:0009966, GO:0009967, GO:0010562, GO:0051246, GO:0051247, GO:0032270, GO:0031399, GO:0048518, GO:0065007, GO:0090092, GO:0045937, GO:0060255, GO:0031323, GO:0050794, GO:0051174, GO:0008150, GO:0042325, GO:0042327, GO:0032268, GO:0031401, GO:0060393, GO:0001932, GO:0001934, GO:0048522
GO:0007493 [BP]endodermal cell fate determinationprobableGO:0048598, GO:0007492, GO:0007369, GO:0030154, GO:0009790, GO:0009653, GO:0007275, GO:0044699, GO:0001706, GO:0001704, GO:0048869, GO:0001709, GO:0048646, GO:0032502, GO:0032501, GO:0009987, GO:0009888, GO:0044767, GO:0044763, GO:0035987, GO:0001711, GO:0045165, GO:0044707, GO:0048856, GO:0060795, GO:0008150
GO:0018107 [BP]peptidyl-threonine phosphorylationprobableGO:0044267, GO:0006468, GO:0009987, GO:0044260, GO:0044238, GO:0019538, GO:0016310, GO:0018210, GO:0043412, GO:0006464, GO:0043170, GO:0071704, GO:0006796, GO:0036211, GO:0008150, GO:0018193, GO:0008152, GO:0006793, GO:0044237
GO:0000082 [BP]G1/S transition of mitotic cell cycleprobableGO:0051325, GO:0044699, GO:0000278, GO:0008150, GO:0009987, GO:0051329, GO:0044770, GO:0044772, GO:0022402, GO:0022403, GO:0044763, GO:0007049
GO:0004702 [MF]receptor signaling protein serine/threonine kinase activityprobableGO:0004674, GO:0016773, GO:0005057, GO:0003824, GO:0016301, GO:0060089, GO:0016740, GO:0003674, GO:0004871, GO:0004672, GO:0016772
GO:0048185 [MF]activin bindingprobableGO:0032403, GO:0003674, GO:0005488, GO:0005515
GO:0016361 [MF]activin receptor activity, type IprobableGO:0038023, GO:0060089, GO:0017002, GO:0016772, GO:0003824, GO:0016301, GO:0016740, GO:0004675, GO:0004674, GO:0004888, GO:0003674, GO:0004872, GO:0004871, GO:0004672, GO:0019199, GO:0016773
GO:0005524 [MF]ATP bindingprobableGO:0043168, GO:0003674, GO:0005488, GO:0030554, GO:0035639, GO:0097159, GO:1901363, GO:0043167, GO:0036094, GO:0032553, GO:0032559, GO:0001883, GO:0032549, GO:0032555, GO:0017076, GO:0000166, GO:0032550, GO:1901265, GO:0001882
GO:0023014 [BP]signal transduction by phosphorylationprobableGO:0044700, GO:0051716, GO:0008152, GO:0016310, GO:0050896, GO:0009987, GO:0044237, GO:0050794, GO:0008150, GO:0006796, GO:0065007, GO:0044763, GO:0007165, GO:0023052, GO:0006793, GO:0007154, GO:0050789, GO:0044699
GO:0001707 [BP]mesoderm formationprobableGO:0032502, GO:0048598, GO:0048856, GO:0001704, GO:0048332, GO:0007498, GO:0007369, GO:0009888, GO:0044767, GO:0009790, GO:0032501, GO:0008150, GO:0044699, GO:0048729, GO:0009653, GO:0007275, GO:0048646, GO:0044707
GO:0009986 [CC]cell surfaceprobableGO:0005575, GO:0044464, GO:0005623
GO:0005025 [MF]transforming growth factor beta receptor activity, type IprobableGO:0038023, GO:0060089, GO:0016773, GO:0016772, GO:0003824, GO:0016301, GO:0016740, GO:0005024, GO:0004675, GO:0004674, GO:0004888, GO:0003674, GO:0004872, GO:0004871, GO:0004672, GO:0019199
GO:0045648 [BP]positive regulation of erythrocyte differentiationprobableGO:0051094, GO:0050793, GO:0045646, GO:0065007, GO:0032844, GO:0045597, GO:0050789, GO:0045595, GO:0045639, GO:0002682, GO:0008150, GO:0051239, GO:0048518, GO:2000026, GO:0050794, GO:0045637, GO:0048522
GO:0046777 [BP]protein autophosphorylationprobableGO:0044267, GO:0006468, GO:0044260, GO:0044238, GO:0019538, GO:0016310, GO:0009987, GO:0043412, GO:0006464, GO:0043170, GO:0071704, GO:0006796, GO:0036211, GO:0008150, GO:0044237, GO:0008152, GO:0006793
GO:0030308 [BP]negative regulation of cell growthprobableGO:0045926, GO:0040008, GO:0051128, GO:0008150, GO:0001558, GO:0065007, GO:0048519, GO:0050794, GO:0050789, GO:0048523
GO:0045944 [BP]positive regulation of transcription from RNA polymerase II promoterprobableGO:0009893, GO:0019222, GO:0031328, GO:0031326, GO:0031325, GO:2001141, GO:0031323, GO:0010628, GO:0050789, GO:0080090, GO:0010604, GO:0051171, GO:0009891, GO:2000112, GO:0019219, GO:0010556, GO:0065007, GO:0048518, GO:0010468, GO:0045935, GO:0060255, GO:0009889, GO:0050794, GO:0008150, GO:0045893, GO:0051173, GO:0051252, GO:0051254, GO:0006355, GO:0010557, GO:0006357, GO:0048522
GO:0048264 [BP]determination of ventral identityprobableGO:0032502, GO:0007389, GO:0032501, GO:0009953, GO:0044707, GO:0009799, GO:0008150, GO:0003002, GO:0009855, GO:0048262, GO:0007275, GO:0044699
GO:1901164 [BP]negative regulation of trophoblast cell migrationprobableGO:2000242, GO:2000241, GO:0050789, GO:0065007, GO:2000145, GO:1901163, GO:0030336, GO:0030334, GO:0050793, GO:0051271, GO:0050794, GO:0043900, GO:0051270, GO:0008150, GO:0051239, GO:0048519, GO:0032879, GO:0040013, GO:0040012, GO:2000026, GO:2000146, GO:0048523
GO:0031101 [BP]fin regenerationprobableGO:0048589, GO:0035107, GO:0009653, GO:0007275, GO:0044699, GO:0040007, GO:0031099, GO:0009611, GO:0032502, GO:0033333, GO:0032501, GO:0033334, GO:0009888, GO:0042060, GO:0044767, GO:0006950, GO:0008150, GO:0044707, GO:0050896, GO:0048856, GO:0042246, GO:0048736
GO:0051291 [BP]protein heterooligomerizationprobableGO:0051259, GO:0022607, GO:0071822, GO:0070271, GO:0043933, GO:0006461, GO:0016043, GO:0065003, GO:0044085, GO:0008150, GO:0071840
GO:0035270 [BP]endocrine system developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0008150, GO:0048731, GO:0007275, GO:0044699
GO:0048568 [BP]embryonic organ developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0009790, GO:0048513, GO:0008150, GO:0048731, GO:0007275, GO:0044699
GO:0008015 [BP]blood circulationprobableGO:0032501, GO:0044707, GO:0003013, GO:0008150, GO:0044699, GO:0003008
GO:0043025 [CC]neuronal cell bodyprobableGO:0005575, GO:0097458, GO:0044297, GO:0005623, GO:0044464
GO:0048705 [BP]skeletal system morphogenesisprobableGO:0032502, GO:0009887, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0001501, GO:0048513, GO:0008150, GO:0048731, GO:0009653, GO:0007275, GO:0044699
GO:0070724 [CC]BMP receptor complexprobableGO:0043234, GO:0043235, GO:0032991, GO:0044459, GO:0016021, GO:0016020, GO:0044464, GO:0005623, GO:0005575, GO:0071944, GO:0005887, GO:0005886, GO:0044425, GO:0031226, GO:0031224
GO:0042078 [BP]germ-line stem cell divisionprobableGO:0048610, GO:0030154, GO:0048468, GO:0019953, GO:0008356, GO:0051301, GO:0000003, GO:0048869, GO:0007276, GO:0032502, GO:0032501, GO:0048609, GO:0032504, GO:0009987, GO:0044767, GO:0022414, GO:0044763, GO:0022412, GO:0007281, GO:0044699, GO:0044702, GO:0003006, GO:0048856, GO:0008150, GO:0017145
GO:0003230 [BP]cardiac atrium developmentprobableGO:0003205, GO:0007507, GO:0032501, GO:0044707, GO:0072358, GO:0048856, GO:0044767, GO:0072359, GO:0048513, GO:0008150, GO:0048731, GO:0032502, GO:0007275, GO:0044699
GO:0009411 [BP]response to UVprobableGO:0008150, GO:0009314, GO:0050896, GO:0009416, GO:0009628
GO:0050431 [MF]transforming growth factor beta bindingprobableGO:0019955, GO:0003674, GO:0019838, GO:0005515, GO:0005488
GO:0032330 [BP]regulation of chondrocyte differentiationprobableGO:0050793, GO:0050794, GO:0008150, GO:0045595, GO:0061035, GO:2000026, GO:0051239, GO:0065007, GO:0050789
GO:0060284 [BP]regulation of cell developmentprobableGO:0050793, GO:0050794, GO:0045595, GO:0008150, GO:0065007, GO:0050789
GO:0016324 [CC]apical plasma membraneprobableGO:0045177, GO:0016020, GO:0044464, GO:0005623, GO:0005575, GO:0071944, GO:0005886, GO:0044425, GO:0044459
GO:0016323 [CC]basolateral plasma membraneprobableGO:0016020, GO:0044464, GO:0005623, GO:0005575, GO:0071944, GO:0005886, GO:0044425, GO:0044459
GO:0046872 [MF]metal ion bindingprobableGO:0043169, GO:0003674, GO:0005488, GO:0043167
GO:0007476 [BP]imaginal disc-derived wing morphogenesisprobableGO:0048563, GO:0048569, GO:0035107, GO:0009887, GO:0035220, GO:0009791, GO:0035120, GO:0002165, GO:0032501, GO:0009653, GO:0007275, GO:0044699, GO:0007472, GO:0007552, GO:0048513, GO:0032502, GO:0048707, GO:0009886, GO:0035114, GO:0008150, GO:0044767, GO:0044707, GO:0007444, GO:0048856, GO:0007560, GO:0048731, GO:0048736, GO:0048737
GO:0018105 [BP]peptidyl-serine phosphorylationprobableGO:0044267, GO:0006468, GO:0018209, GO:0044260, GO:0044238, GO:0019538, GO:0016310, GO:0009987, GO:0043412, GO:0006464, GO:0043170, GO:0071704, GO:0006796, GO:0036211, GO:0008150, GO:0018193, GO:0008152, GO:0006793, GO:0044237
GO:0045446 [BP]endothelial cell differentiationprobableGO:0032502, GO:0060429, GO:0003158, GO:0030154, GO:0009888, GO:0008150, GO:0044763, GO:0048869, GO:0030855, GO:0009987, GO:0044699, GO:0048856
GO:0070700 [MF]BMP receptor bindingprobableGO:0033612, GO:0003674, GO:0005488, GO:0005515, GO:0005102, GO:0070696
GO:0043066 [BP]negative regulation of apoptotic processprobableGO:0043069, GO:0050794, GO:0008150, GO:0043067, GO:0065007, GO:0060548, GO:0048519, GO:0010941, GO:0042981, GO:0050789, GO:0048523
GO:0043062 [BP]extracellular structure organizationprobableGO:0009987, GO:0016043, GO:0008150, GO:0044699, GO:0044763, GO:0071840
GO:0001837 [BP]epithelial to mesenchymal transitionprobableGO:0030154, GO:0048468, GO:0009653, GO:0007275, GO:0044699, GO:0014031, GO:0048864, GO:0000902, GO:0048869, GO:0016043, GO:0032989, GO:0008150, GO:0048513, GO:0071840, GO:0032502, GO:0048762, GO:0032501, GO:0009987, GO:0009888, GO:0044767, GO:0048863, GO:0044763, GO:0060485, GO:0000904, GO:0044707, GO:0048856, GO:0048731
GO:0007162 [BP]negative regulation of cell adhesionprobableGO:0030155, GO:0050794, GO:0008150, GO:0065007, GO:0048519, GO:0050789, GO:0048523
GO:0045669 [BP]positive regulation of osteoblast differentiationprobableGO:0051094, GO:0050793, GO:0045595, GO:0050794, GO:0045597, GO:0045667, GO:0065007, GO:0051239, GO:0048518, GO:0008150, GO:0030278, GO:0050789, GO:0048522
GO:0001945 [BP]lymph vessel developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0001944, GO:0044767, GO:0072359, GO:0072358, GO:0008150, GO:0048731, GO:0007275, GO:0044699
GO:0005901 [CC]caveolaprobableGO:0045121, GO:0016020, GO:0044464, GO:0005623, GO:0005575, GO:0071944, GO:0005886, GO:0044425, GO:0044459
GO:1901383 [BP]negative regulation of chorionic trophoblast cell proliferationprobableGO:0042127, GO:0008285, GO:0050794, GO:0008150, GO:0065007, GO:1901382, GO:0048519, GO:0050789, GO:0048523
GO:0010629 [BP]negative regulation of gene expressionprobableGO:0009892, GO:0019222, GO:0060255, GO:0050789, GO:0008150, GO:0065007, GO:0048519, GO:0010605, GO:0010468
GO:0001667 [BP]ameboidal cell migrationprobableGO:0040011, GO:0048870, GO:0009987, GO:0006928, GO:0051674, GO:0044763, GO:0008150, GO:0016477, GO:0051179, GO:0044699
GO:0007181 [BP]transforming growth factor beta receptor complex assemblyprobableGO:0022607, GO:0070887, GO:0070271, GO:0043933, GO:0034622, GO:0023052, GO:0007165, GO:0007166, GO:0007167, GO:0050789, GO:0071840, GO:0009719, GO:0051716, GO:0071822, GO:0070848, GO:0016043, GO:0065003, GO:0071310, GO:0065007, GO:0044699, GO:0071559, GO:0071495, GO:0009987, GO:0006461, GO:0050794, GO:0042221, GO:0008150, GO:0007154, GO:0043623, GO:0010033, GO:0007179, GO:0007178, GO:0044700, GO:0071363, GO:0050896, GO:0071560, GO:0044085, GO:0044763
GO:0009952 [BP]anterior/posterior pattern specificationprobableGO:0032502, GO:0007389, GO:0032501, GO:0044707, GO:0008150, GO:0003002, GO:0007275, GO:0044699
GO:0043010 [BP]camera-type eye developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0007423, GO:0048856, GO:0044767, GO:0048513, GO:0001654, GO:0008150, GO:0048731, GO:0007275, GO:0044699
GO:0060541 [BP]respiratory system developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0008150, GO:0048731, GO:0007275, GO:0044699
GO:0031396 [BP]regulation of protein ubiquitinationprobableGO:0032268, GO:0080090, GO:0019222, GO:0060255, GO:0051246, GO:0031323, GO:0050794, GO:0065007, GO:0031399, GO:0008150, GO:0050789
GO:0031625 [MF]ubiquitin protein ligase bindingprobableGO:0003674, GO:0044389, GO:0005515, GO:0019899, GO:0005488
GO:0010596 [BP]negative regulation of endothelial cell migrationprobableGO:0030336, GO:0040013, GO:0030334, GO:0010594, GO:0010632, GO:0010633, GO:0065007, GO:0051271, GO:0040012, GO:0008150, GO:0051270, GO:2000145, GO:0051239, GO:2000146, GO:0048519, GO:0032879, GO:0050794, GO:0050789, GO:0048523
GO:0048732 [BP]gland developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0048513, GO:0008150, GO:0048731, GO:0007275, GO:0044699
GO:0001525 [BP]angiogenesisprobableGO:0032502, GO:0032501, GO:0044707, GO:0001568, GO:0048856, GO:0001944, GO:0044767, GO:0072359, GO:0072358, GO:0048514, GO:0048646, GO:0048731, GO:0008150, GO:0009653, GO:0007275, GO:0044699
GO:0060037 [BP]pharyngeal system developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0009790, GO:0009792, GO:0008150, GO:0048731, GO:0043009, GO:0007275, GO:0044699
GO:0043627 [BP]response to estrogen stimulusprobableGO:0009719, GO:0033993, GO:0050896, GO:0008150, GO:0048545, GO:0009725, GO:0042221, GO:0010033, GO:0014070
GO:0032927 [BP]positive regulation of activin receptor signaling pathwayprobableGO:0090092, GO:0032925, GO:0090100, GO:0009966, GO:0009967, GO:0048584, GO:0048583, GO:0050794, GO:0023056, GO:0065007, GO:0023051, GO:0048518, GO:0008150, GO:0010647, GO:0010646, GO:0050789, GO:0048522
GO:2000017 [BP]positive regulation of determination of dorsal identityprobableGO:0051094, GO:0050793, GO:0051240, GO:2000015, GO:0008150, GO:2000026, GO:0051239, GO:0048518, GO:0065007, GO:0050789
GO:0030509 [BP]BMP signaling pathwayprobableGO:0080090, GO:0019222, GO:0031326, GO:0031323, GO:0023052, GO:0007165, GO:0007166, GO:0007167, GO:0050789, GO:0044699, GO:0051716, GO:2000112, GO:0060255, GO:0006357, GO:0065007, GO:0010468, GO:0019219, GO:0009987, GO:0009889, GO:0050794, GO:0044763, GO:0051171, GO:2001141, GO:0007154, GO:0007178, GO:0044700, GO:0050896, GO:0051252, GO:0006355, GO:0010556, GO:0008150
GO:0030501 [BP]positive regulation of bone mineralizationprobableGO:0070169, GO:0045778, GO:0050793, GO:0051240, GO:0051094, GO:0070167, GO:0008150, GO:0048518, GO:2000026, GO:0051239, GO:0030500, GO:0065007, GO:0030278, GO:0050789
GO:0030182 [BP]neuron differentiationprobableGO:0032502, GO:0048699, GO:0009987, GO:0044707, GO:0007399, GO:0048869, GO:0030154, GO:0008150, GO:0032501, GO:0044763, GO:0048731, GO:0022008, GO:0007275, GO:0044699, GO:0048856
GO:0001824 [BP]blastocyst developmentprobableGO:0032502, GO:0001701, GO:0044707, GO:0032501, GO:0048856, GO:0044767, GO:0009790, GO:0009792, GO:0008150, GO:0043009, GO:0007275, GO:0044699
GO:0060391 [BP]positive regulation of SMAD protein import into nucleusprobableGO:0033157, GO:0032388, GO:0060341, GO:0051049, GO:0032386, GO:0048584, GO:0048583, GO:0070201, GO:0023056, GO:0023051, GO:0010647, GO:0010646, GO:0051222, GO:0032880, GO:0051223, GO:0090100, GO:0009966, GO:0009967, GO:0050789, GO:0065007, GO:0048518, GO:0090092, GO:0051050, GO:0090316, GO:0050794, GO:0008150, GO:0042307, GO:0042306, GO:0032879, GO:1900180, GO:0060390, GO:0046824, GO:0046822, GO:0048522
GO:0022603 [BP]regulation of anatomical structure morphogenesisprobableGO:0050793, GO:0008150, GO:0065007, GO:0050789
GO:0090101 [BP]negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathwayprobableGO:0090092, GO:0009968, GO:0009966, GO:0048585, GO:0048583, GO:0050794, GO:0008150, GO:0023057, GO:0065007, GO:0010648, GO:0023051, GO:0048519, GO:0010646, GO:0050789, GO:0048523
GO:0048641 [BP]regulation of skeletal muscle tissue developmentprobableGO:1901861, GO:0016202, GO:0050793, GO:0048634, GO:0008150, GO:2000026, GO:0051239, GO:0065007, GO:0050789
GO:0005771 [CC]multivesicular bodyprobableGO:0005737, GO:0043231, GO:0043227, GO:0005770, GO:0044464, GO:0043229, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424, GO:0005768, GO:0043226
GO:0005938 [CC]cell cortexprobableGO:0005737, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0071944, GO:0044424
GO:0006955 [BP]immune responseprobableGO:0002376, GO:0050896, GO:0008150
GO:0034711 [MF]inhibin bindingprobableGO:0003674, GO:0005488, GO:0005515
GO:0036122 [MF]BMP bindingprobableGO:0019955, GO:0003674, GO:0005488, GO:0005515
GO:0042803 [MF]protein homodimerization activityprobableGO:0046983, GO:0003674, GO:0005515, GO:0042802, GO:0005488
GO:0072001 [BP]renal system developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0008150, GO:0001655, GO:0048731, GO:0007275, GO:0044699
GO:0033036 [BP]macromolecule localizationprobableGO:0008150, GO:0051179
GO:0042118 [BP]endothelial cell activationprobableGO:0008150, GO:0001775, GO:0009987, GO:0044763, GO:0044699
GO:0005160 [MF]transforming growth factor beta receptor bindingprobableGO:0005126, GO:0005102, GO:0003674, GO:0005488, GO:0005515
GO:0038100 [MF]nodal bindingprobableGO:0003674, GO:0005488, GO:0005515
GO:0045603 [BP]positive regulation of endothelial cell differentiationprobableGO:0051094, GO:0050793, GO:0045595, GO:0050794, GO:0045597, GO:0045601, GO:0065007, GO:0030856, GO:0008150, GO:0051239, GO:0048518, GO:2000026, GO:0030858, GO:0050789, GO:0048522
GO:0045602 [BP]negative regulation of endothelial cell differentiationprobableGO:0051093, GO:0050793, GO:0045595, GO:0050794, GO:0008150, GO:0045596, GO:0045601, GO:0065007, GO:0030856, GO:0030857, GO:0051239, GO:0048519, GO:2000026, GO:0050789, GO:0048523
GO:0006917 [BP]induction of apoptosisprobableGO:0050789, GO:0043067, GO:0050794, GO:0043065, GO:0048518, GO:0012502, GO:0065007, GO:0010942, GO:0008150, GO:0010941, GO:0042981, GO:0043068, GO:0048522
GO:0003143 [BP]embryonic heart tube morphogenesisprobableGO:0032502, GO:0009790, GO:0072359, GO:0072358, GO:0009653, GO:0007275, GO:0044699, GO:0002009, GO:0048513, GO:0048729, GO:0060562, GO:0048598, GO:0009887, GO:0032501, GO:0035239, GO:0060429, GO:0035050, GO:0009888, GO:0003007, GO:0008150, GO:0035295, GO:0007507, GO:0044707, GO:0048856, GO:0044767, GO:0048731
GO:0060840 [BP]artery developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0001568, GO:0048856, GO:0001944, GO:0044767, GO:0072359, GO:0072358, GO:0008150, GO:0048731, GO:0007275, GO:0044699
GO:0030900 [BP]forebrain developmentprobableGO:0032502, GO:0044707, GO:0007420, GO:0007399, GO:0032501, GO:0048856, GO:0044767, GO:0048513, GO:0008150, GO:0048731, GO:0007275, GO:0044699, GO:0007417
GO:0035108 [BP]limb morphogenesisprobableGO:0032502, GO:0048856, GO:0044707, GO:0060173, GO:0035107, GO:0044767, GO:0032501, GO:0008150, GO:0044699, GO:0009653, GO:0007275, GO:0048736
GO:0030425 [CC]dendriteprobableGO:0044464, GO:0005623, GO:0005575, GO:0097458, GO:0043005, GO:0042995
GO:0051897 [BP]positive regulation of protein kinase B signaling cascadeprobableGO:0023051, GO:0009966, GO:0010740, GO:0048584, GO:0048583, GO:0050794, GO:0023056, GO:0050789, GO:0065007, GO:0009967, GO:0048518, GO:0008150, GO:0010647, GO:0010646, GO:0010627, GO:0051896, GO:0048522
GO:0070723 [BP]response to cholesterolprobableGO:1901700, GO:0033993, GO:0050896, GO:0008150, GO:0042221, GO:0036314, GO:0097305, GO:0010033, GO:0014070
GO:0043280 [BP]positive regulation of cysteine-type endopeptidase activity involved in apoptotic processprobableGO:0019222, GO:2001056, GO:0007569, GO:0010941, GO:0042981, GO:0050789, GO:0043085, GO:0051345, GO:2000116, GO:0043067, GO:0065007, GO:0044699, GO:0044093, GO:0043281, GO:0065009, GO:0010259, GO:0009987, GO:0052547, GO:0052548, GO:0006915, GO:0050794, GO:0012501, GO:0044763, GO:0010950, GO:0010952, GO:0051336, GO:0050790, GO:0008150
GO:0048179 [CC]activin receptor complexprobableGO:0043234, GO:0043235, GO:0032991, GO:0044459, GO:0016021, GO:0016020, GO:0044464, GO:0005623, GO:0005575, GO:0071944, GO:0005887, GO:0005886, GO:0044425, GO:0031226, GO:0031224
GO:0019827 [BP]stem cell maintenanceprobableGO:0030154, GO:0048468, GO:0050789, GO:0044699, GO:0048863, GO:0048864, GO:0048869, GO:0065007, GO:0048519, GO:0032502, GO:0032501, GO:0050793, GO:0009987, GO:0050794, GO:0044767, GO:0045596, GO:0045595, GO:0008150, GO:0051093, GO:0044707, GO:0048856, GO:0044763, GO:0048523
GO:0048477 [BP]oogenesisprobableGO:0044702, GO:0048609, GO:0032504, GO:0019953, GO:0007292, GO:0022414, GO:0032501, GO:0008150, GO:0044699, GO:0007276, GO:0000003
GO:0030513 [BP]positive regulation of BMP signaling pathwayprobableGO:0090092, GO:0010646, GO:0090100, GO:0009966, GO:0009967, GO:0048584, GO:0048583, GO:0050794, GO:0023056, GO:0065007, GO:0023051, GO:0048518, GO:0008150, GO:0010647, GO:0048522, GO:0050789, GO:0030510
GO:0051216 [BP]cartilage developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0009888, GO:0061448, GO:0001501, GO:0048513, GO:0008150, GO:0048731, GO:0007275, GO:0044699
GO:0060389 [BP]pathway-restricted SMAD protein phosphorylationprobableGO:0016310, GO:0023052, GO:0007165, GO:0007166, GO:0007167, GO:0050789, GO:0044699, GO:0044267, GO:0051716, GO:0044260, GO:0071704, GO:0065007, GO:0006468, GO:0044238, GO:0009987, GO:0006464, GO:0050794, GO:0043412, GO:0036211, GO:0044763, GO:0008152, GO:0007154, GO:0007178, GO:0044700, GO:0019538, GO:0050896, GO:0044237, GO:0043170, GO:0006796, GO:0006793, GO:0008150
GO:0065008 [BP]regulation of biological qualityprobableGO:0008150, GO:0065007
GO:0000981 [MF]sequence-specific DNA binding RNA polymerase II transcription factor activityprobableGO:0003700, GO:0003674, GO:0001071
GO:0051130 [BP]positive regulation of cellular component organizationprobableGO:0051128, GO:0065007, GO:0048518, GO:0008150, GO:0050794, GO:0050789, GO:0048522
GO:0046545 [BP]development of primary female sexual characteristicsprobableGO:0032502, GO:0007548, GO:0032501, GO:0000003, GO:0044707, GO:0022414, GO:0045137, GO:0003006, GO:0008150, GO:0046660, GO:0007275, GO:0044699
GO:0040014 [BP]regulation of multicellular organism growthprobableGO:0008150, GO:0040008, GO:0065007, GO:0050789, GO:0051239
GO:0030307 [BP]positive regulation of cell growthprobableGO:0045927, GO:0040008, GO:0051128, GO:0001558, GO:0065007, GO:0048518, GO:0008150, GO:0050794, GO:0050789, GO:0048522
GO:0051960 [BP]regulation of nervous system developmentprobableGO:0050793, GO:0008150, GO:0065007, GO:0051239, GO:2000026, GO:0050789
GO:0003197 [BP]endocardial cushion developmentprobableGO:0032502, GO:0007507, GO:0032501, GO:0044707, GO:0048513, GO:0048856, GO:0009888, GO:0044767, GO:0072359, GO:0072358, GO:0008150, GO:0048731, GO:0060485, GO:0007275, GO:0044699
GO:0061371 [BP]determination of heart left/right asymmetryprobableGO:0032502, GO:0007507, GO:0032501, GO:0044707, GO:0007389, GO:0048513, GO:0007368, GO:0048856, GO:0044767, GO:0072359, GO:0072358, GO:0008150, GO:0009855, GO:0009799, GO:0048731, GO:0007275, GO:0044699
GO:0001942 [BP]hair follicle developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0022405, GO:0009888, GO:0022404, GO:0048513, GO:0008150, GO:0042633, GO:0048731, GO:0008544, GO:0042303, GO:0007275, GO:0044699
GO:0038092 [BP]nodal signaling pathwayprobableGO:0044700, GO:0051716, GO:0032924, GO:0008150, GO:0050896, GO:0009987, GO:0050794, GO:0023052, GO:0065007, GO:0044763, GO:0007165, GO:0007166, GO:0007167, GO:0007154, GO:0050789, GO:0044699, GO:0007178
GO:0000186 [BP]activation of MAPKK activityprobableGO:0019220, GO:0009893, GO:0019222, GO:0033674, GO:0031325, GO:0048583, GO:0032147, GO:0023051, GO:0010646, GO:0010627, GO:0050789, GO:0043085, GO:0043408, GO:0051347, GO:0010604, GO:0009966, GO:0010562, GO:0043549, GO:0051246, GO:0051247, GO:0032270, GO:0044093, GO:0031399, GO:0048518, GO:0065007, GO:0065009, GO:0050790, GO:0045937, GO:0060255, GO:0031323, GO:0045859, GO:0080090, GO:0050794, GO:0051174, GO:0032268, GO:0008150, GO:0042325, GO:0042327, GO:0045860, GO:0031401, GO:0051338, GO:0001932, GO:0001934, GO:0048522
GO:0044087 [BP]regulation of cellular component biogenesisprobableGO:0008150, GO:0065007, GO:0050789, GO:0050794
GO:0008283 [BP]cell proliferationprobableGO:0008150, GO:0044699
GO:0051260 [BP]protein homooligomerizationprobableGO:0051259, GO:0022607, GO:0071822, GO:0070271, GO:0043933, GO:0006461, GO:0016043, GO:0065003, GO:0044085, GO:0008150, GO:0071840
GO:0005923 [CC]tight junctionprobableGO:0005575, GO:0070160, GO:0043296, GO:0030054, GO:0005911
GO:0048534 [BP]hematopoietic or lymphoid organ developmentprobableGO:0032502, GO:0002376, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0048513, GO:0008150, GO:0048731, GO:0007275, GO:0044699, GO:0002520
GO:0001938 [BP]positive regulation of endothelial cell proliferationprobableGO:0008284, GO:0042127, GO:0050678, GO:0050679, GO:0050794, GO:0065007, GO:0048518, GO:0008150, GO:0001936, GO:0050789, GO:0048522
GO:0001937 [BP]negative regulation of endothelial cell proliferationprobableGO:0042127, GO:0008285, GO:0050678, GO:0050680, GO:0050794, GO:0008150, GO:0065007, GO:0048519, GO:0050789, GO:0048523, GO:0001936

Prediction of Enzyme Commission Number ?

No confident prediction of EC number!

Spatial Structural Prediction

Structural Models Based on Templates

Template: 1B6C, chain B
Confidence level:very confident
Coverage over the Query: 1-59
View the alignment between query and template
View the model in PyMOL